Evidence map›Paper›PMID 24772392›Full record

ReviewFrontiers in cellular and infection microbiology2014

That's my story, and I'm sticking to it--an update on B. burgdorferi adhesins.

Catherine A Brissette, Robert A Gaultney

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Borrelia surface proteins: new horizons in Lyme disease diagnosis.Applied microbiology and biotechnology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Tick-to-host transmission differs betweenMicrobiology spectrum · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Identification of amino acid domains ofFrontiers in cellular and infection microbiology · 2022
    Article
  14. Article
  15. Pathogens (Basel, Switzerland) · 2021
    Article
  16. Lyme Disease Pathogenesis.Current issues in molecular biology · 2021
    Review
  17. Lyme Disease in Humans.Current issues in molecular biology · 2021
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Catherine A BrissetteDepartment of Basic Sciences, University of North Dakota School of Medicine and Health Sciences Grand Forks, ND, USA.
Robert A GaultneyDepartment of Basic Sciences, University of North Dakota School of Medicine and Health Sciences Grand Forks, ND, USA.

Funding

Role of Borrelia burgdorferi Rev fibronectin binding proteins in Lyme diseaseK22AI093671 · NIAID · UNIVERSITY OF NORTH DAKOTA · PI BRISSETTE, CATHERINE AYN · 2011 to 2012
$270k
NIAID NIH HHS 1K22AI093671-01NIAID NIH HHS K22 AI093671
6 · The paper itself

Abstract

Adhesion is the initial event in the establishment of any infection. Borrelia burgdorferi, the etiological agent of Lyme disease, possesses myriad proteins termed adhesins that facilitate contact with its vertebrate hosts. B. burgdorferi adheres to host tissues through interactions with host cells and extracellular matrix, as well as other molecules present in serum and extracellular fluids. These interactions, both general and specific, are critical in the establishment of infection. Modulation of borrelial adhesion to host tissues affects the microorganisms's ability to colonize, disseminate, and persist. In this review, we update the current knowledge on structure, function, and role in pathogenesis of these "sticky" B. burgdorferi infection-associated proteins.

Indexed as

Bacterial AdhesionAdhesins, BacterialAnimalsBorrelia burgdorferiHumansVirulenceAdhesins, Bacterialbacterial adhesinsBorrelia burgdorferidecorinextracellular matrixfibronectinintegrinsLyme disease

Identifiers

PMID24772392
PMCPMC3982108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.